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pathway, essential for development,
activates processing of NF-kB2/p100 into
p52. Two protein kinases, NIK and
IKK1/a, are central components of this
pathway. Polley et al. identify a unique
surface on IKK1/a based on the X-ray and
cryo-EM structures, and they find that it is
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Distinct signaling pathways activate the NF-kB fam-
ily of transcription factors. The canonical NF-kB-
signaling pathway is mediated by IkB kinase 2/b
(IKK2/b), while the non-canonical pathway depends
on IKK1/a. The structural and biochemical bases
for distinct signaling by these otherwise highly
similar IKKs are unclear. We report single-particle
cryoelectronmicroscopy (cryo-EM) and X-ray crystal
structures of human IKK1 in dimeric (150 kDa) and
hexameric (450 kDa) forms. The hexamer, which
is the representative form in the crystal but com-
prises only 2% of the particles in solution by cryo-
EM, is a trimer of IKK1 dimers. While IKK1 hexamers
are not detectable in cells, the surface that supports
hexamer formation is critical for IKK1-dependent
cellular processing of p100 to p52, the hallmark of
non-canonical NF-kB signaling. Comparison of this
surface to that in IKK2 indicates significant diver-
gence, and it suggests a fundamental role for this
surface in signaling by these kinases through distinct
pathways.
INTRODUCTION
NF-kB family transcription factors are central to cellular immune
and inflammatory responses and cell survival in higher eukary-
otes (Baldwin, 2001; Xiao and Ghosh, 2005). Loss of regulation
and consequent aberrant NF-kB activity lead to various patho-
logical conditions, including chronic inflammatory andmetabolic
diseases, autoimmune disorders, and cancer (Ben-Neriah and
Karin, 2011; Grivennikov et al., 2010; Xia et al., 2014). Under ho-
meostatic conditions, NF-kB activity is maintained at a low,
basal level through cytoplasmic sequestration via noncovalent
binding to IkB (inhibitor of NF-kB) proteins (Hinz and Scheidereit,
2014). The transcriptional potential of NF-kB is realized upon
IkB removal as a result of activation of one of two distinct
NF-kB-signaling pathways, referred to as canonical and non-
canonical (also known as alternative) (Bonizzi et al., 2004). Two
highly homologous Ser/Thr kinases, IKK2/IKKb and IKK1/IKKa,
act as central regulators of these two pathways (Ghosh and
Karin, 2002; Sun, 2012).Cell Repo
This is an open access article under the CC BY-NIKK2, which is present within a holo-IKK complex that is pre-
sumed to contain also IKK1 and the NEMO/IKKg scaffolding pro-
tein, regulates the canonical pathway of NF-kB activation that is
essential for inflammation and innate immunity in response to
pathogens (DiDonato et al., 1997). IKK2 is primarily responsible
(Li et al., 1999) for the phosphorylation of specific residues
of prototypical IkB proteins (IkBa, -b, and -ε) bound to NF-kB
as well as an atypical IkB protein, NF-kB1/p105, which is the
precursor of the NF-kB subunit p50 (Karin and Ben-Neriah,
2000). Phosphorylation-dependent ubiquitylation and proteaso-
mal degradation of the IkBproteins (or partial processing of p105
to p50) lead to the release of active NF-kB dimers (Hayden and
Ghosh, 2008).
In contrast, IKK1 regulates NF-kB signaling through the non-
canonical pathway, which is essential for lymphoid organo-
genesis and adaptive immunity. IKK1 phosphorylates specific
residues of NF-kB2/p100 on its C-terminal IkBd segment. This
leads to processing of p100 and generation of the NF-kB subunit
p52 (Claudio et al., 2002; Coope et al., 2002; Dejardin et al.,
2002; Senftleben et al., 2001; Sun, 2012). Interestingly, genera-
tion of p52 through the non-canonical pathway is critically
dependent on another kinase domain-containing cellular factor,
NF-kB-inducing kinase (NIK) (Xiao et al., 2001, 2004), but it does
not rely on either IKK2 or NEMO. In resting cells, NIK level is kept
low through its continuous proteasome-dependent degradation
(Qing et al., 2005; Vallabhapurapu et al., 2008; Zarnegar et al.,
2008). However, upon stimulation of cells by non-canonical li-
gands, and in certain malignant cells, NIK is stabilized from pro-
teolysis to the extent that it becomes capable of recruiting and
inducing the kinase activity of IKK1. Kinase activities of both
NIK and IKK1 are essential for efficient processing of p100 into
p52 (Sun, 2012). IKK1 and NIK phosphorylate three serines
(866, 870, and 872) of NF-kB2/p100 within its C-terminal IkBd
segment, leading to the processing of p100 to p52.
The X-ray crystal structure of Xenopus IKK2 provided insight
into domain organization, dimer assembly, and substrate-
binding features in IKK family kinases (Xu et al., 2011). Subse-
quent X-ray structures of human IKK2 provided further insights
into the mechanism through which IKK2 becomes catalytically
active (Polley et al., 2013). However, these IKK2 structures
have failed to shed light on the question of how either IKK1
or IKK2, in response to different upstream stimuli, act to regu-
late such a wide range of NF-kB-dependent activities (Hinz
and Scheidereit, 2014; Scheidereit, 2006). As part of our effort
to understand the mechanistic basis underlying the uniquerts 17, 1907–1914, November 15, 2016 ª 2016 The Authors. 1907
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Determination of the Structure of Human IKK1
(A) Domain organization is as follows: KD, kinase domain; ULD, ubiquitin-like domain; SDD, scaffold dimerization domain; and NBD, NEMO-binding domain.
Functionally relevant residues and those mutated in this study are marked.
(B) Representative 2D class averages of cryo-EM particles of hIKK1 are shown.
(C and D) Initial cryo-EM model (C) and refined cryo-EM map (D) of the hIKK1 dimer without classification are shown.
(E) Crystallographic model of an hIKK1 dimer derived from the X-ray data is shown.
(F) hIKK1 protomer with its three domains in different shades of red is shown.signaling function of IKK1, we report the three-dimensional
(3D) structures of human IKK1 determined by combining
cryoelectron microscopy (cryo-EM) and X-ray crystallography.
These structures reveal an unexpected trimeric arrangement
of IKK1 dimers that gives rise to a hexamer. Cellular and
biochemical studies indicate that the IKK1 hexameric assem-
bly is of insufficient stability to be clearly observed in cell.
However, mutation of residues on IKK1 that mediate its
hexamerization results in a drastic impairment of the non-
canonical NF-kB-signaling pathway. This study provides a
glimpse into the structure of IKK1, reveals how structural fea-
tures that are unique to IKK1 contribute to its role in non-
canonical NF-kB signaling, and identifies possible tools and
approaches for the specific regulation of signal-induced ac-
tivity of IKK1.
RESULTS
Determination of Human IKK1Structure byCryo-EMand
X-Ray Crystallography
In an effort to crystallize human IKK1 (hIKK1), we generated
various truncation mutants with both wild-type (WT) and the
S176E,180E (EE) double mutant in which two activation loop
serine residues were replaced with phosphomimetic gluta-
mates (Figure 1A). Only one construct of hIKK1 (residues
10–667; EE) reproducibly yielded crystals suitable for X-ray1908 Cell Reports 17, 1907–1914, November 15, 2016diffraction analysis in the presence of the Calbiochem IKK
inhibitor XII (Christopher et al., 2007). However, attempts at
phase determination by molecular replacement, using IKK2 di-
mers in various conformations (Liu et al., 2013; Polley et al.,
2013; Xu et al., 2011) as search models, failed. This was some-
what unexpected, as sequence alignments and homology
modeling analyses predicted the domain arrangement and
mode of dimerization for IKK1 to be similar to those in IKK2.
The two proteins share 50% identity and 70% homology
(Figure S1).
To prepare better search models for molecular replacement,
we turned to single-particle cryo-EM. The expected species of
IKK1 in solution is a dimer with a molecular weight (MW) of
150 kDa, which is considered small by cryo-EM standards.
However, various recent advances have pushed the resolution
limit and reduced the size limitation of the approach (Bai et al.,
2015; Cheng, 2015). Micrographs of purified IKK1 revealed par-
ticles that resembled IKK2 dimers and yielded an initial map with
clearly resolved domains and a-helical features (Figures 1B–1D;
Figures S2A and S2B). This cryo-EM map was used to dock in-
dividual domains of an IKK1 homology model that was gener-
ated using a crystal structure of IKK2 (PDB: 4KIK). The resultant
model yielded a molecular replacement solution for our X-ray
diffraction data (Table S1). Further analyses of the cryo-EM
data enabled us to refine structural models to5.5 A˚ (discussed
later).
Features of Human IKK1 Structure
The cryo-EMand X-ray crystal structures revealed that, like other
IKK family members IKK2 and TBK1, IKK1 forms a dimer (Fig-
ure 1E) and the individual IKK1 subunit is composed of three
ordered protein domains: a kinase domain (KD), a ubiquitin-like
domain (ULD), and a scaffold dimerization domain (SDD) (Fig-
ure 1F). The backbone architectures of individual domains are
highly conserved among IKK family proteins.
The overall structural features of IKK1 observed in cryo-EM
and X-ray maps were highly consistent; however, we used the
X-ray map to describe the structure due to better resolution.
The KD adopts the familiar fold observed in other canonical pro-
tein kinases. Backbone electron density for the activation loop is
clearly visible (Figure S2C), and positioning of important catalytic
site residues indicates that the KD is in an active conformation.
Density for the inhibitor is relatively well defined, and we were
able to position it sensibly within the Fo-Fc omit density map (Fig-
ure S2D). The ULD, which has been implicated previously in sub-
strate specificity (Gray et al., 2014), indeed adopts a fold that is
similar to that of ubiquitin (Figure 1F). It also contains a unique
17-residue loop insertion spanning residues 367–383, the gen-
eral path of which is visible in the density. The SDD, a long stalk-
like structure composed of an anti-parallel three-helix bundle,
provides an extensive surface for dimerization on one end.
Two long a helices, a2 s and a6 s of the SDD, run parallel to
each other and are accompanied by a discontinuous, anti-paral-
lel third helical segment composed of a3 s, a4 s, and a5 s (Fig-
ure 1F). The dimer interfaces of IKK1 and IKK2 are highly similar,
containing conserved residues and burying 3,400-A˚2 surface
area (Figure S1) (Polley et al., 2013; Xu et al., 2011).
Despite global similarity among IKK monomers, their tertiary
organizations reflect significant differences in relative placement
of all three domains. The most pronounced difference between
IKK1 and IKK2 was observed in the orientation of the KD relative
to the SDD and its stably associated ULD. Previous studies indi-
cated that spatial arrangement and inter-domain connectivity
are critical for the activity of IKK2. In IKK2, the KD is positioned
appropriately with respect to the SDD and ULD through interac-
tions of several residues in ULD (L389 and F390), SDD (W434
and H435), and KD (F111 and E112). Mutation of these residues
reduced kinase activity of IKK2, with W434 and H435 mutants
displaying a drastic reduction (Polley et al., 2013). Interest-
ingly, most of these residues are conserved in IKK1, except for
W434 and F111 (Figure S1).
A major advantage of single-particle cryo-EM is the ability to
detect structural heterogeneity within the data. To assess the
conformational plasticity of IKK1, we analyzed particles using
maximum likelihood-based 3D classification and simultaneous
refinement (Lyumkis et al., 2013). This analysis revealed three
predominant conformational states of IKK1 dimers (with an
approximately uniform distribution), the maps of which were
subsequently refined to average global resolutions of 5.6,
5.4, and 5.2 A˚ (Figures S3A–S3D; Table S2). The resulting
maps enabled independent construction of three molecular
models describing IKK1 flexibility using recently developed pro-
tocols implemented within Rosetta and Phenix (Figure 2A).
These models display differing angles between apposing KDs
and suggest mobility of IKK1 domains (Figure S3E). Interestingly,the splaying of two KDs in all six independent dimers within the
X-ray lattice is similar (Figure S3F), the extent of which is similar
to the least-splayed dimer model from cryo-EM (Figure 2B; Fig-
ure S3G). Overall, our X-ray and cryo-EM analyses revealed
distinct conformers of the IKK1 dimer that are reminiscent of
the conformational plasticity observed in IKK2 (Polley et al.,
2013) and could explain the difficulty in obtaining well-diffracting
IKK1 crystals.
IKK1 Self-Assembles into a Trimer of Dimers, a Hexamer
The most intriguing finding observed in both X-ray and cryo-EM
data is the assembly of three IKK1 dimers into a hexamer. The
asymmetric unit contained two independent hexamers, each of
which formed through the self-association of three IKK1 dimers
(Figure 2C). We also detected a small population of particles
(2%) in the cryo-EM data that did not conform to particles
yielding high-resolution dimer structures (Figure 2D). A careful
inspection of these 1,432 particles through iterative two-dimen-
sional (2D) sub-classification (Figure 2D, right panel) resulted in a
density map of5.9-A˚ resolution that contained a D3-symmetric
IKK1 hexamer (Figures 2E and 2F; Figures S3I–S3K). It is likely
that the 3-fold symmetry of the hexamer was selected for the
single dimer conformation observed within the crystal; this
observation was supported by a more uniform local resolution
for the reconstructed EM map of the hexamer (Figure S3I).
The observation of hexameric IKK1 assemblies by two inde-
pendent methods and the overall similarity between crystallo-
graphic and EM hexamers suggest that hexamerization through
a trimer interface is specific to and an inherent property of
the IKK1 protein. Moreover, since cryo-EM analyses were per-
formed under solution conditions, in the absence of any inhibitor,
and at low protein concentration, assembly of IKK1 into hexam-
ers is likely to have biological relevance.
Three IKK1 dimers associate with 3-fold symmetry to form the
IKK1 hexamer. The close-knit trimer interface involves the KD
and SDD of each protomer and buries a surface area of about
6,300 A2. Interacting patches of the buried trimer interface can
be classified into three groups: KD-KD, KD-SDD, and SDD-
SDD (Figure 2G). In the KD-SDD interface, residues within the
L21-G27 stretch from the KD of one protomer are in close prox-
imity to N408, Y409, and Q412 of the SDD in another protomer.
Residues within the H573-Y580 loop of SDD from all three proto-
mers closely associate to form the SDD-SDD interface. In the
KD-KD interface, residues in the S249-E251 loop closely appose
P227-F228. Interestingly, despite their high degree of sequence
and structural homology, most of these interacting residues at
the trimer interface in IKK1 are not conserved in IKK2, providing
an explanation for the absence of a similar assembly in IKK2.
Overexpressed IKK1 Exists as Dimers in the Cell
The specific interaction of IKK1 dimers at the trimer interface
prompted our investigation as to whether IKK1 exists as a hex-
amer in cells and whether perturbation of residues within the
trimer interface destabilizes hexamerization and non-canonical
NF-kB signaling. Within the trimer interface, we selected resi-
dues for mutation that could potentially disrupt inter-protomer
interactions without perturbing kinase catalytic fold and/or activ-
ity. We concentrated primarily on residues of the SDD to disruptCell Reports 17, 1907–1914, November 15, 2016 1909
Figure 2. Cryo-EM and X-Ray Structures of Human IKK1
(A) Atomic models of three different conformers superimposed on a transparent isosurface representation of their respective cryo-EM maps are shown.
(B) Superposition of three IKK1 dimer conformers modeled from the cryo-EM maps (orange, yellow, and green) and the X-ray model (purple) is shown as pipes.
(C) Crystallographic model of the IKK1 hexamer (surface representation) with constituent trimers is shown.
(D) Left panel: representative 2D cryo-EM class averages of hIKK1 representing the complete dataset (this panel is identical to Figure 1B). Right panel: 2D class
averages of hIKK1 after sub-classification of the class outlined in green are shown.
(E) Initial cryo-EM map of IKK1 hexamer calculated from sub-classified class averages is shown.
(F) Cryo-EM map of IKK1 hexamer refined from raw particles to 5.9-A˚ resolution is shown.
(G) A cartoon and a schematic representation of the trimer interface formed by monomers from three dimers constituting the hexamer. Zoomed-in views show
the three interactive patches (KD:SDD, KD:KD, and SDD:SDD) of the interface with interacting residues highlighted.both SDD-SDD and SDD-KD interactions. A double-mutant
IKK1HY (H578A Y580A, SDD-SDD) was chosen for this assay.
IKK1WT and IKK1HY with native activation loop sequences were
overexpressed as HA-fusion proteins in 293T cells, and their
oligomerization status wasmonitored by size-exclusion chroma-
tography of S100 extracts followed by immunoblot analysis
of the fractions with anti-HA antibody (Figure 3A). Both overex-
pressed IKK1WT and IKK1HY were found to be mostly dimeric.1910 Cell Reports 17, 1907–1914, November 15, 2016Analysis of insect cell-expressed pure IKK1 by Superose 6
size-exclusion chromatography also revealed the dimer to be
the predominant form of IKK1 in solution, with only a very small
fraction eluting as a large oligomer (Figure 3B). Similar size-
exclusion experiments aimed at assessing the oligomeric state
of purified IKK2 indicated that it exists exclusively as a dimer
(Figure 3B), and IKK2 in mammalian cell extracts is known to
exist predominantly as a dimer. Overall, these results clearly
Figure 3. Oligomerization Property of IKK1 in Cells
(A) Size-exclusion profiles of overexpressed IKK1 (WT and HY mutant) and IKK2 in S100 extracts of 293T cells. Protein levels are assessed by western blot and
normalized band intensities are plotted.
(B) Size-exclusion profiles of IKK1 (1–676) and IKK2 (1–700) proteins expressed in insect cells and purified to homogeneity. Absorbance at 280 nm reflects the
level of proteins.
(C) Size-exclusion profiles of endogenous IKK1 in S100 extract of MEF cells and HA-IKK1WT and HA-IKK1HY in S100 extract of stably reconstituted ikk1/MEF
cells. Protein levels are assessed by western blot.show that overexpressed IKK1 exists predominantly as a dimer.
It is noteworthy that native IKK1 in mouse embryonic fibroblast
(MEF) 3T3 cells predominantly migrates within an uncharacter-
ized large complex, as indicated by a western blot analysis
for IKK1 (Figure 3C), likely in association with IKK2 and NEMO
(1 MDa). We reconstituted ikk1/ MEF cell lines with HA-
IKK1WT and HA-IKK1HY, and we compared the oligomeric prop-
erties of WT and mutant IKK1 proteins, where expression levels
of the proteins are in a similar range to that of the native protein.
These experiments revealed that the mutant behaved similarly
to the WT protein. However, these fractionation experiments
were not sensitive enough to clearly distinguish the presence
of a minor population of oligomeric IKK1 from dimeric free
IKK1 or the uncharacterized holo-IKK complex.
Perturbation of the IKK1 Trimer Interface Leads to
Pathway-Specific Inhibition of NF-kB Activation
It has been established that formation of a NEMO:IKK2 complex
is indispensable for the activation of NF-kB through the canoni-cal pathway. In the non-canonical pathway, however, the inter-
action between NIK and IKK1 is essential. To clarify the distinct
role of IKK1 in the non-canonical signaling, we assayed for IKK-
specific signaling events in MEF cells. Consistent with previous
findings, we observed that processing of p100 to p52 upon treat-
ment with lymphotoxin b receptor agonist antibody (a-LTbR) is
drastically reduced in ikk1/ MEF cells compared to that in
WT and ikk2/ MEF cells (Figure S4A). In contrast, canonical
NF-kB signaling, as reflected by rapid degradation of IkBa sub-
strate in response to TNF-a, is severely compromised only in
ikk2/ MEF cells and not in WT or ikk1/ MEFs (Figure S4B).
These differences in cellular functions also were observed
in an in vitro kinase assay where IKK1 and IKK2 preferentially
phosphorylated the IkBd portion of p100 and IkBa, respectively
(Figure S4C). These observations underscore the functional
uniqueness of two otherwise highly homologous kinases
IKK1 and IKK2, which share 70% homology, an identical
domain arrangement, and a nearly identical kinase activation
segment.Cell Reports 17, 1907–1914, November 15, 2016 1911
Figure 4. Mutant IKK1 Abrogates Non-canonical NF-kB Signaling
(A) ikk1/MEF cells fail to induce p100 processing in response to a-LTbRwhen trimer interfacemutants of IKK1 (IKK1HY and IKK1NY) are introduced. Introduction
of native IKK1 enables processing similarly to the WT MEF; signaling is monitored by immunoblotting with anti-p52.
(B) IKK1 trimer interface mutants do not affect the characteristic IkBa degradation profile in response to TNF-a treatment during canonical NF-kB signaling, as
monitored by immunoblotting with anti-IkBa.
(C) The trimer interface mutant (IKK1HY) shows a defect in binding to NIK when compared to WT IKK1. NIK recruitment efficiencies of native and mutant IKK1
proteins were assessed in a co-immunoprecipitation assay.
(D) Residues of IKK1 involved in forming the trimer interface and those of IKK2 in tetramer-forming interfaces in the crystal lattice are shown in context of
the respective monomers. Overlapping patches in SDD and KD that contain interacting residues are highlighted. A few prominent residues and the general active
site area are marked.Wewished to investigate if the structural surfaces thatmediate
the unique trimerization of IKK1 dimers into hexamers might be
critical for non-canonical signaling in vivo. We tested IKK1HY
(H578A Y580A) and another double mutant, IKK1NY (N408A
Y409A), that target the SDD-KD patch of the trimer interface.
Processing of p100 to p52 was monitored in ikk1/ MEF cells
retrovirally transduced with IKK1HY and IKK1NY in response to
a-LTbR treatment over different time periods. These reconsti-
tuted MEFs failed to exhibit any appreciable processing of
p100 to p52, while the extent and kinetics of p100 processing
in ikk1/ MEF cells reconstituted with native IKK1 (IKK1WT)
were similar to that ofWTMEFs (Figure 4A). This reflects a severe
disruption of NF-kB activation through the non-canonical
pathway, with IKK1 harboring trimer interface mutations. In
both IKK1HY and IKK1NY reconstituted cells, the characteristic
IkBa degradation profile upon treatment with TNF-a was
observed (Figure 4B), confirming that the canonical NF-kB-
signaling pathway is mostly unaffected. These findings suggest
that trimer interface interactions are essential for non-canonical
NF-kB signaling but have little or no apparent relevance in
canonical signaling.1912 Cell Reports 17, 1907–1914, November 15, 2016Since propagation of a non-canonical signal depends on pro-
ductive association between IKK1 and NIK, we next tested
whether the surface of IKK1 containing HY is required for the
recruitment of IKK1 to NIK. Different amounts of HA-tagged
IKK1 (WT and HY) were mixed with constant amounts of Myc-
NIK, all proteins being expressed in HEK293T cells and obtained
from its total extract. Immunoprecipitation with anti-Myc anti-
body and western blot analysis with anti-HA antibody indicated
that the trimer interface-defective (IKK1HY) mutant exhibited
partial reduction in binding to NIK as compared to the WT IKK1
(Figure 4C).
DISCUSSION
In this study, we identified a surface on IKK1 that is essential for
the processing of p100 to p52 through the non-canonical NF-kB-
signaling pathway. Initial experiments suggest that this surface is
involved in the interaction of IKK1 with NIK. It is possible that the
IKK1:NIK interaction through this surface is essential for IKK1
activation, which is one of the key initial events in the propaga-
tion of non-canonical signaling. Intriguingly, residues from the
homologous surface on IKK2 have been shown to be essential
for its activation (Figure 4D). We speculate that the two IkB
kinases may undergo activation by similar mechanisms. In the
case of IKK2, the surface in question might be responsible for
a signal-dependent interaction with NEMO. This signal-depen-
dent interaction is separate from the stable binding observed
between NEMO and IKK2 through their N and C termini,
respectively.
Intriguingly, these functionally important homologous surfaces
of IKK1 and IKK2were both identified on account of their involve-
ment in self-assembly within their respective crystal lattices (also
from the solution structure of IKK1). We have thus far failed to
relate self-assembly of IKK1 (or IKK2) to their function in cells.
It is still possible that aberrant activation upon unintended inter-
action with NIK or other non-canonical signaling factor(s) is
curbed through dynamic engagement of this surface through
self-oligomerization in unstimulated cells. We also cannot rule
out the possibility that regulated formation of IKK1 oligomers
leads to the appropriate docking of partner proteins and thereby
its activation. It is known that, only after NIK is permitted to accu-
mulate within the cell and become activated via non-canonical
signaling, the proper activation of IKK1 can occur through its
interaction with NIK and p100. Thus, insight into the dynamic
interplay of these three factors is key to understanding non-ca-
nonical NF-kB signaling. Our study highlights important surface
patches in IKK1 that could likely be targeted to prevent its
assembly with NIK and p100 and, thus, selectively block the
activation of NF-kB through the non-canonical pathway.
One of the critical unresolved questions regarding IKK is the
composition of IKK complex(es) in vivo. The predominant form
of IKK is presumed to be a heterotrimeric IKK complex (IKK1:
IKK2:NEMO). This complex, which appears to be in the high-
MW range (1 MDa), as judged by size-exclusion chromatog-
raphy, has been studied extensively by different groups since its
discovery (Li et al., 2001; Miller and Zandi, 2001; Solt et al.,
2009). It is possible that NEMO, which interacts with both IKK1
and IKK2, is responsible for the elution of the complex as high
MW. The canonical signaling triggered by stimuli, such as TNF-a
and lipopolysaccharide (LPS), activates this high-MW complex,
as indicated by IkBa phosphorylation activity of IKK2 contained
within this pool. It is unclear whether IKK1 present in this complex
propagates a non-canonical NF-kB signal. Our structures and
preliminary cellular signaling data set up a platform to further
investigate the biochemical nature and forms of IKK1 that could
be targeted by NIK during non-canonical signaling.EXPERIMENTAL PROCEDURES
Protein expression, purification, X-ray structure determination, cryo-EM data
acquisition, cryo-EM image analysis, IKK1-dimer model building and refine-
ment from cryo-EM data, immunoprecipitation assays, in vitro kinase assays
(IP-KA), retroviral reconstitution of MEF cells, cellular signaling assays, and
size-exclusion chromatography to assess oligomeric status are described in
detail in the Supplemental Experimental Procedures.ACCESSION NUMBERS
The accession numbers for the EMmaps of the three conformers of IKK1 dimer
and that for the IKK1 hexamer reported in this paper are EMDataBank: EMD-8436, EMD-8437, EMD-8438, and EMD-8439, respectively. The accession
numbers for the coordinates for the three conformers of IKK1 dimer refined
using EM maps reported in this paper are PDB: 5TQW, 5TQX, and 5TQY.
The accession number for the atomic coordinates and structure factors of
human IKK1 model refined from crystallographic data reported in this paper
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